Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma
1 other identifier
interventional
195
1 country
2
Brief Summary
BACKGROUND Asthma is a prevalent and troublesome pediatric condition. In 2013, Emergency Department (ED) providers treated over 3,500 cases of asthma-related complaints at Children's Hospitals and Clinics of Minnesota. Pediatric ED visits for asthma exceeds billions of dollars annually when including direct cost and lost productivity. Many of these visits and resultant costs are avoidable. Patients with well-controlled asthma do not typically exhibit these patterns, while patients with poorly controlled asthma show patterns of increased utilization of healthcare resources and lower quality of life. Evidence suggests that a text message reminder and educational program might positively influence pediatric asthma care practices. RESEARCH QUESTION Does a targeted ED based text message intervention program improve outpatient follow-up and routine preventive care in pediatric asthma patients? METHODS Study subjects will be block randomized based on age and insurance group. The experimental group will receive text messages with guidance towards follow-up care with their PCP and the importance of the flu vaccine for children with asthma. The control group will receive a series of educational self-care and health based text messages unrelated to asthma or the flu vaccine. Some self-report of behaviors will be captured via text message response. ANALYSIS Primary outcomes for the educational versus targeted text message groups will be compared use Chi-square tests. Additional adjustments may be applied for missing data or if, despite randomization, there is substantial imbalance between group in key covariates (eg race/ethnicity, insurance type or asthma severity.)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable asthma
Started Oct 2014
Longer than P75 for not_applicable asthma
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 1, 2015
CompletedFirst Posted
Study publicly available on registry
May 6, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedNovember 22, 2017
November 1, 2017
4.2 years
May 1, 2015
November 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Follow-up care with primary care provider
Assessed via text and follow-up call if no response to text message
1 week after emergency department discharge
Secondary Outcomes (2)
Influenza vaccine
30 days after emergency department discharge
Return visit to the emergency department
30 days after the inaugural emergency department visit
Study Arms (2)
Control
ACTIVE COMPARATORSubjects receive general, health-related text messages applicable for children with asthma.
Test group
EXPERIMENTALSubjects receive specific, targeted text messages for post-emergency department discharge asthma care.
Interventions
Subjects received text messages specific to post ED asthma follow-up
Subjects received text messages generalized to children with asthma
Eligibility Criteria
You may qualify if:
- Caregivers of patients aged 4 - 17 years (inclusive) will be eligible for study participation if they meet the following criteria:
- Presentation to the ED with a chief complaint related to an asthma exacerbation such as shortness of breath, respiratory distress, wheezing, etc…
- Receive an albuterol treatment in the ED
- Previous history of asthma as represented in the medical record or by parental report
- Have a cell phone that is able to receive text messages
- Able to communicate and provide consent in English or Spanish
You may not qualify if:
- Caregivers of patients will be excluded from this study for the following reasons:
- First episode of wheezing
- Admitted to the hospital
- Co-morbid respiratory disease:
- Cystic fibrosis
- Bronchiectasis
- Pulmonary hypertension
- Other chronic lung disease
- Current cancer diagnosis
- Previous cardiovascular surgery
- Inflammatory bowel disease
- Sickle Cell disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Children's Hospitals and Clinics of Minnesota - Emergency Department
Minneapolis, Minnesota, 55404, United States
Children's Minnesota
Saint Paul, Minnesota, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2015
First Posted
May 6, 2015
Study Start
October 1, 2014
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
November 22, 2017
Record last verified: 2017-11